Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node
Open Access
- 20 April 2012
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 21 (4) , 524-528
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Occult Axillary Node Metastases in Breast Cancer Are Prognostically Significant: Results in 368 Node-Negative Patients With 20-Year Follow-UpJournal of Clinical Oncology, 2008
- Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled studyThe Lancet Oncology, 2006
- Morbidity After Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results From a Randomized Controlled TrialJournal of Clinical Oncology, 2005
- Comparison of morbidity between axillary lymph node dissection and sentinel node biopsyEuropean Journal of Surgical Oncology, 2003
- Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedureBreast Cancer Research and Treatment, 2001
- Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients with Breast CancerAnnual Review of Medicine, 2000
- The Impact of Prophylactic Axillary Node Dissection on Breast Cancer Survival?A Bayesian Meta-AnalysisAnnals of Surgical Oncology, 1999
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI: Journal of the National Cancer Institute, 1998
- Improved Axillary Staging of Breast Cancer with Sentinel LymphadenectomyAnnals of Surgery, 1995
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985